14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
XDSQ vs XBOC: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Innovator U.S. Equity Accelerated 9 Buffer ETF - October (XBOC) is the stronger overall head-to-head candidate over Innovator U.S. Equity Accelerated ETF - Quarterly (XDSQ) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). XDSQ carries a Unified Composite Score of 59.5/100 (HOLD) at $43.40 (N/M Forward P/E, N/A operating margin), whereas XBOC carries 58.7/100 (HOLD) at $35.94 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While XDSQ currently prints a higher short-term Unified Composite Score (59.5/100 HOLD vs. XBOC 58.7/100 HOLD), XBOC captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Technical & Structure Timing Caution: XDSQ trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 40.6); meanwhile XBOC is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 42.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XDSQ vs XBOC. Trailing 12-month operating profitability (XDSQ N/A vs XBOC N/A) and valuation multiples (XDSQ N/M vs XBOC N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ XDSQ vs XBOC Key Questions & Quantitative Answers
As of Nov 16, 2026, Innovator U.S. Equity Accelerated 9 Buffer ETF - October (XBOC) is the stronger overall head-to-head candidate over Innovator U.S. Equity Accelerated ETF - Quarterly (XDSQ) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). XDSQ carries a Unified Composite Score of 59.5/100 (HOLD) at $43.40 (N/M Forward P/E, N/A operating margin), whereas XBOC carries 58.7/100 (HOLD) at $35.94 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While XDSQ currently prints a higher short-term Unified Composite Score (59.5/100 HOLD vs. XBOC 58.7/100 HOLD), XBOC captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: XDSQ trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 40.6); meanwhile XBOC is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 42.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
XDSQ and XBOC split Growth & Scale metrics: XDSQ posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with XBOC at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, XDSQ generates N/A in USD-normalized revenue versus N/A for XBOC. In operating R&D and SG&A reinvestment, XDSQ deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for XBOC.
XDSQ and XBOC trade at balanced relative valuation multiples. XDSQ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas XBOC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against XDSQ (N/A ROE) versus XBOC (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, XDSQ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.77β · 24% Vol realized risk). By comparison, XBOC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.45β · 14% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.